Financial Performance - The company's revenue for Q1 2025 was CNY 1,041,603,772.08, representing a 2.76% increase compared to CNY 1,013,580,318.64 in the same period last year[7] - Net profit attributable to shareholders decreased by 10.90% to CNY 72,115,093.50 from CNY 80,937,582.74 year-on-year[7] - The basic earnings per share decreased by 10.64% to CNY 0.1302 from CNY 0.1457 in the same period last year[7] - Net profit for the current period was ¥81,361,076.86, a decrease of 11.06% from ¥91,621,188.01 in the previous period[31] Cash Flow - The net cash flow from operating activities significantly improved to CNY 197,078,619.88, a 723.31% increase from a negative CNY 31,618,218.42 in the previous year[7] - Cash inflow from operating activities totaled ¥1,221,076,384.98, compared to ¥1,000,955,439.65 in the prior period, an increase of 22.05%[32] - The net cash flow from investment activities amounted to ¥44,818,011.39, marking a substantial increase of 596.28%[14] - Cash inflow from financing activities totaled ¥95,764,138.73, up 282.81% from the prior period[14] - The net cash flow from investing activities was 9,030,795.06 in the previous period[33] - Net cash flow from financing activities was negative at -67,652,512.86 in the prior period[33] Assets and Liabilities - Total assets at the end of Q1 2025 were CNY 5,993,652,578.88, down 1.70% from CNY 6,097,564,952.38 at the end of the previous year[7] - The total liabilities decreased to ¥2,143,592,172.82 from ¥2,327,948,769.86, indicating a reduction of 7.91%[29] - The company's non-current assets totaled CNY 3.67 billion, down from CNY 3.72 billion, reflecting a decrease of 1.95%[28] - Short-term borrowings significantly decreased to CNY 25.03 million from CNY 130.08 million, a reduction of 80.69%[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,418, with no preferred shareholders[17] - The largest shareholder, Li Shaobo, holds 25.29% of the shares, amounting to 142,685,648 shares, with 107,014,236 shares pledged[17] - The company plans to repurchase shares with a total amount not less than CNY 150 million and not exceeding CNY 300 million, with a maximum repurchase price of CNY 34.00 per share[23] - Vice Chairman Li Xinyi increased her shareholding by acquiring 62,600 shares at an average price of CNY 24.72 per share, totaling CNY 1.55 million, which represents 0.01% of the total share capital[24] Government Support and Expenses - The company received government subsidies amounting to CNY 5,790,840.98 during the reporting period[8] - Financial expenses increased by 543.61% to CNY 5,529,943.74 due to foreign exchange losses from a subsidiary[12] - The company reported a significant increase in tax refunds received, totaling CNY 31,872,657.56, a 39.39% increase from CNY 22,865,422.67 in the previous year[13] - The company reported a significant increase in tax payments, totaling ¥82,091,472.56, which is a 35.81% increase year-over-year[14] Inventory and Receivables - Accounts receivable decreased to CNY 529.52 million from CNY 620.26 million, reflecting a decline of 14.66%[27] - The company’s inventory stood at CNY 659.37 million, slightly down from CNY 662.84 million, a decrease of 0.37%[27] Accounting and Reporting - The company did not have an audited first-quarter report for 2025[34] - The company will implement new accounting standards starting from 2025[34]
三诺生物(300298) - 2025 Q1 - 季度财报